Multicenter Open Label Phase 3 Benefit Study of Isatuximab Plus Lenalidomide and Dexamethasone With/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients. IFM2020-05Arthur Bobin,Cyrille Hulin,Jerome Lambert,Aurore Perrot,Salomon Manier,Lydia Montes,Arnaud Jaccard,Lionel Karlin,Pascal Godmer,Denis Caillot,Thomas Chalopin,Christophe Roul,Clara Mariette,Sophie Rigaudeau,Jacques Delaunay,Claire Dingremont,Alberto Santagostino,Mamoun Dib,Margaret Macro,Mourad Tiab,Kamel Laribi,Emmanuelle Bourgeois Petit,Claire Calmettes,Frederique Orsini Piocelle,Benoit Bareau,Reza Tabrizi,Laure Vincent,Mohamad Mohty,Cyrille Touzeau,Jill Corre,Philippe Moreau,Thierry Facon,Herve Avet Loiseau,Xavier LeleuBLOOD（2023）引用 0|浏览9关键词International Myeloma Working GroupAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
